Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for Scleroderma

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Belumosudil in Subjects with Diffuse Cutaneous Systemic Sclerosis

    Scottsdale/Phoenix, AZ

  2. A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis

    Scottsdale/Phoenix, AZ

  4. A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis

    Rochester, MN

  5. Assessment of Sleep Disorder Breathing Risk in Patients with Scleroderma

    Scottsdale/Phoenix, AZ

  6. Collection of Gastrointestinal and Fatigue Data in Scleroderma (Ssc) Patients at Mayo Clinic Arizona

    Scottsdale/Phoenix, AZ, Rochester, MN


Mayo Clinic Footer